LakeShore Biopharma (LSB) F-4 Registration of securities (foreign)

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM   We consent to the use in this Registration Statement on Form F-4 of YishengBio Co., Ltd. of our report dated September 28, 2022, relating to the consolidated financial statements of YishengBio Co., Ltd. and Subsidiaries for the years ended March 31, 2022 and 2021, which appear in this Registration Statement.   We also consent to the reference to us under the heading “Experts” in such Registration Statement.   /s/ Wei, Wei & Co., LLP   Flushing, New York December 28, 2022

1